IIM
DXCM icon

Ipswich Investment Management’s DexCom DXCM Stock Holding History

Ipswich Investment Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,524
Closed -$211K – 189
2024
Q1 		$211K Buy
+1,524
New +$192K 0.05% 186
2022
Q2 		– Sell
-1,568
Closed -$201K – 180
2022
Q1 		$201K Hold
1,568
– – 0.05% 187
2021
Q4 		$210K Buy
1,568
+60
+4% +$8.62K 0.05% 194
2021
Q3 		$206K Buy
+1,508
New +$190K 0.05% 188

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ipswich Investment Management's DXCM Position: Q2 2024 in Review

Ipswich Investment Management sold out of DexCom (DXCM) in Q2 2024, closing a stake of 1,524 shares — an estimated $211K sold.

Ipswich Investment Management first reported a position in DXCM in Q3 2021 and held it in 4 quarters. The position peaked at $211K in Q1 2024. 999 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • Ipswich Investment Management reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • Ipswich Investment Management sold 1,524 DexCom shares in Q2 2024, an estimated $211K.
  • Ipswich Investment Management first reported a position in DexCom in Q3 2021 and held it in 4 quarters.
  • Ipswich Investment Management's DexCom position peaked at $211K in Q1 2024.
  • 999 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Ipswich Investment Management's 13F filing for Q2 2024, filed 16 Jul 2024.